Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.

Journal of viral hepatitis - 1 Nov 2013

Ackefors M, Nyström J, Wernerson A, Gjertsen H, Sönnerborg A, Weiland O

Abstract excerpt

The IL-28 gene is associated with sustained viral response (SVR) after treatment with peg-IFN and ribavirin in liver transplant recipients with chronic hepatitis C genotype 1 infection. We analysed the importance of recipient and donor IL-28B genotype for response to treatment and fibrosis progression in 54 liver transplant recipients. Fibrosis stage (F) was defined as mild when F≤2 and severe when F≥3 in a liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferons

Share to Interleukins

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Recurrence

Share to Ribavirin

Source

Identifiers

PMID: 24168256
DOI: 10.1111/jvh.12099

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.PMID 24168256Read ↗

The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.Semantic proximity Read ↗

Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.Semantic proximity Read ↗

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.Semantic proximity Read ↗

Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.Semantic proximity Read ↗

CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.Semantic proximity Read ↗

IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury.Semantic proximity Read ↗

Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.Semantic proximity Read ↗

Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients.Semantic proximity Read ↗

Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.Semantic proximity Read ↗

A model to predict severe HCV-related disease following liver transplantation.Semantic proximity Read ↗

Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.Semantic proximity Read ↗

Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.